Printer Friendly

MEXICAN HEALTH DEPARTMENT APPROVES HARRIER'S BIOPTRON LAMP

 MEXICAN HEALTH DEPARTMENT APPROVES HARRIER'S BIOPTRON LAMP
 LOS ANGLES, March 4 /PRNewswire/ -- Harrier, Inc. (NASDAQ: HARE) said notification has been received from the Mexican Secretariat of Health that its Bioptron Lamp(R) has been approved as a prescriptive device for sale to doctors and hospitals in that country for the treatment of dermatological and rheumatological ailments. The company noted that any claims being made for the product in the Mexican consumer market would be reviewed by the Health Department on an ongoing basis.
 The Bioptron Lamp utilizes linearly polarized incoherent light of specific wavelength distribution and power density to produce a biostimulative effect on cellular tissue. Independent tests conducted here and abroad suggest that the light activates and possibly enhances the cells' natural processes.
 The Lamp is currently being sold in a number of European and Asian countries primarily as a skin care cosmetic product, although several countries have approved its use in medical applications such as arthritis and wound healing. Although Harrier has sold the lamp in the U.S. on a limited basis as a cosmetic device since July 1991, it continues to sponsor clinical and biological studies to determine the likelihood of achieving FDA approval.
 Harrier announced last Fall that it had entered into an exclusive five-year distribution agreement with Planeta Gmbh., a large European direct selling organization, effective Jan. 1, 1992. The contract calls for Planeta to take a minimum of 40,000 units in the first year, with escalating numbers thereafter. Harrier noted that the units appeared to be selling well, and that Planeta was meeting or exceeding its minimum monthly requirements under the contract.
 -0- 3/4/92
 /CONTACT: Kevin DeVito of Harrier Inc., 213-376-7721/
 (HARE) CO: Harrier Inc. ST: Calfiornia IN: HEA SU:


TS-KW -- NY038 -- 4889 03/04/92 10:58 EST
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Mar 4, 1992
Words:299
Previous Article:ASSET INVESTORS CORP. DECLARES FIRST QUARTER DIVIDEND OF 50 CENTS PER SHARE
Next Article:SOUTH FLORIDA ATTORNEY OFFICIALLY IN LINE OF SUCCESSION TO THE FLORIDA BAR PRESIDENCY
Topics:


Related Articles
HARRIER CONTRACTS TO SELL BIOPTRON LAMP SUBSIDIARY; RETAINS EXCLUSIVE DISTRIBUTION RIGHTS IN WESTERN HEMISPHERE
HARRIER CLOSES AMENDED BIOPTRON SALE AGREEMENT
HARRIER CLOSES AMENDED BIOPTRON SALE AGREEMENT
HARRIER ESTABLISHES BIOCHEMICAL SUBSIDIARY
HARRIER REPORTS FISCAL SECOND QUARTER, SIX MONTHS RESULTS
HARRIER REACQUIRES MANUFACTURING RIGHTS TO BIOPTRON LAMP; PLANS TO START PRODUCTION IN U.S. UNDER CONTRACT
NATURADE INC. ANNOUNCES RECORD REVENUES AND EARNINGS FOR FISCAL YEAR
HARRIER INC. REPORTS FISCAL THIRD QUARTER, NINE MONTHS RESULTS
HARRIER TO CO-DEVELOP CALORIMETER WITH ABBOTT LABORATORIES
Creative Enterprises International, Inc. to Unveil Revolutionary Cosmetic Light Therapy System at International Beauty Show; Company to Market FDA...

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters